The Food and Drug Administration has revealed that the maker of a brand of eye drops linked to an outbreak of fatal bacterial infections failed to follow multiple safety protocols.
The FDA visited a Global Pharma Healthcare facility in India for an inspection in mid-February and found dozens of issues ranging from dirty equipment and clothing to missing safeguards and procedures.
The inspection came two-and-a-half weeks after the company voluntarily recalled the EzriCare artificial tears product because of possible contamination.
When the recall was issued, there were already 55 reports of adverse events, including eye infections, permanent loss of vision, and at least one death from a bloodstream infection.
If you return to the office after working from home and feel like you're spending more money, you're not alone this year. That's according to a new report.
New York is trying to restrict algorithms that target young users on social media platforms, introducing two new bills that are designed to protect children's mental health.
Delta Airlines today reported third-quarter profits that beat expectations, boosting its full-year growth outlook, as the carrier earnings increased about 60% to $1.1 billion.
